|
|
|||||||||||||||||||||||
Article Navigation
|
The Risk of recurrence in prostate cancerby: Fritz Frei Prostate cancer disease Prostate cancer - the most common form of cancer in men is Prostate cancer, the second leading cause of cancer death. The Main risk factors include age (incidence increases in men over the age of 65 years). It is more prevalent in the western world and about 10% of cases can be linked to family history. The recurrance Rate of the prostate cancer is high. Mostly, the Prostate cancer is a continuum; progressing through localized, locally advanced, advanced and hormone-refractory stages In general it is a slow growing cancer. He is primarily under hormonal control i.e. testosterone. The choice of treatments which include watchful waiting, surgery (prostatectomy), radiotherapy, hormonal therapy and chemotherapy are dependent on the stage of disease. 1. Most important, that If detected early, using PSA determination, DRE examination and biopsies, and treated appropriately, survival rates are excellent. 2. The most critical focus for the treatment of prostate cancer is to treat those cancers where it is necessary. 3. The Decisions about the best management of prostate cancer can be very complex and depend upon the: - Pathology of the cancer (unlike other cancers, prostate cancer often progresses very slowly) - The impact that treatment can have on quality of life, including sexual activity - Stage of the disease (non-metastatic (localized or locally advanced), metastatic or hormone refractory) - Age and general health of the patients at diagnosis - Patient’s preference for treatment - PSA at diagnosis 4. The treatment options for prostate cancer are: - Deferred treatment often called ‘watchful waiting’ or 'active surveillance' - Surgery – Radical Prostatectomy - Radiotherapy – External Beam and/or Brachytherapy -Hormonal (endocrine) therapy – Androgen Ablation e.g. anti-androgens, medical castration (LHRHa) or surgical castration - Chemotherapy - Palliative Therapy e.g. chemotherapy - Investigational Therapies Prostate Cancer Recurrence Rates *** Prostate cancer is now detected at earlier stages due to heightened awareness and improved screening techniques. Despite definitive therapy, cancer cells may remain and can go undetected for years until they develop into metastatic disease. The risk of recurrence is high, suggesting there is a need to improve treatment approaches. Therefore, it is important to predict pathological stage and risk of disease recurrence early, so that appropriate treatment and/or monitoring can be initiated. The result's of all new treatments will bring us in the future the chance of a lower prostate recurrance. **You can inform you about the recurrence Rates on: http://www.prostateline.com/prostatelinehcp/9898_15850_8_0_0.aspx This gives you an overview with a study case – and the results. Health-Service-Online Admin Fritz http://www.cancer-info.info Latest Cancer News:Cancer Connection: Survivor's guilt can be painful side effect of cancer People going through cancer treatment at the same time often form their own peer group. They see each other in chemo, in radiation and in various support groups. The fortunate ones do well, but they often feel guilty when others in their cohort succumb to the disease. Cancer institute celebrates opening of expansion LITTLE ROCK ? Forty cancer survivors shared the stage with dignitaries such as Gov. Mike Beebe and former U.S. Sen. David Pryor at a ceremony today marking the opening of a 12-story expansion to the Winthrop P. Rockefeller Cancer Institute. Cancer Research UK launches new £18 million Biotherapeutics Development Unit Cancer Research UK's Drug Development Office marks the launch of its Biotherapeutics Development Unit (BDU) today (Friday) with the manufacture of its first product - an antibody for treating a range of cancers. Cancer Vaccine: 4 Months of Life Worth $100K? Prostate cancer vaccine, Provenge, adds 4 months to life, at a pricetag of 100K. The first-ever approved cancer vaccine, Provenge offers hope to men with advanced prostate cancer, but the high cost of this new treatment raises healthcare policy questions. Prostate cancer - Sipuleucel-T - Cancer - Cancer vaccine - Health CÁNCER (Julio 30) CÁNCER: No olvides desarrollar tu trabajo con organización y perseverancia. Trata de hacer algo totalmente nuevo; tus amistades serán tus mejores aliadas. Breast Cancer's DNA Yields More Secrets Title: Breast Cancer's DNA Yields More Secrets Category: Health News Created: 7/29/2010 2:10:00 PM Last Editorial Review: 7/30/2010 Cancer Group Says State Failing To Combat Disease The American Cancer Society released a statement saying Tennessee is falling short on legislative efforts to fight the disease. Cancer patients in windpipe swap op Doctors have successfully transplanted windpipes into two cancer patients in an innovative procedure that uses stem cells to allow a donated trachea to regenerate tissue and create an organ biologically close to the original. Related Stories Two killed in Los Angeles explosion Billy the Kid pardon considered Chelsea Clinton set to tie the knot Everglades added to UN danger list Wilders denied ... Cancer survivors show how to LiveStrong Oklahoma cancer patients and survivors will pitch for a future free of cancer at the annual LiveStrong Night with the Oklahoma City RedHawks. Turner Mason Swink, an Oklahoma City eighth-grader first diagnosed with cancer when he was only a year old, and 8-year-old Caitlin Schemmel, a third-grader from Colbert diagnosed with leukemia in December, will throw out the first pitch at the event ... Male Breast Cancer In Family Leads To High Perception Of Risk, Low Likelihood Of Genetic Counseling People with a family history of male breast cancer perceive themselves to be at higher risk of developing the disease than do patients with a family history of female breast cancer; however those with male breast cancer in their families are less likely to know about or seek genetic testing than those with a family history of female breast cancer, according to a study led by researchers at the ... Showtime stays true to form with 'The Big C,' a cancer comedy - Dallas Morning News
|
||||||||||||||||||||||
Copyright © 2006 CancerAdvice.org